Brief: Egetis Therapeutics Q3 Loss Widens To SEK 53.9 Mln
Nov 8 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* Q3 REVENUES MSEK 5.1 (6.2)
* Q3 LOSS MSEK -53.9 (-18.8)
Source text for Eikon: ID:nMFN9DZ7qn
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1